A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.

[1]  T. Rabelink,et al.  Progressive vascular damage in hypertension is associated with increased levels of circulating P‐selectin , 1998, Journal of hypertension.

[2]  M. Omata,et al.  Circadian variation of paroxysmal atrial fibrillation. , 1997, Circulation.

[3]  J. Sixma,et al.  The Origin of P-selectin as a Circulating Plasma Protein , 1997, Thrombosis and Haemostasis.

[4]  K. Bachmann,et al.  Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. , 1997, Chest.

[5]  G. Lip,et al.  Hypothesis: is soluble P-selectin a new marker of platelet activation? , 1997, Atherosclerosis.

[6]  R. Fijnheer,et al.  Soluble P-selectin as Parameter for Platelet Activation during Storage , 1996, Thrombosis and Haemostasis.

[7]  M. Boffa,et al.  Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker? , 1996, Haemostasis.

[8]  J. Jansson,et al.  Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. , 1996, European heart journal.

[9]  G. Lip,et al.  Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. , 1996, Circulation.

[10]  J. Piette,et al.  Plasma levels of thrombomodulin in pulmonary hypertension. , 1996, The American journal of medicine.

[11]  K. Wulff,et al.  Large-scale screening for factor V Leiden mutation in a north-eastern German population. , 1996, Haemostasis.

[12]  G. Lip.  Does atrial fibrillation confer a hypercoagulable state? , 1995, The Lancet.

[13]  A. Blann,et al.  von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis , 1995, Thrombosis and Haemostasis.

[14]  A. Terashi,et al.  Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation. , 1995, Stroke.

[15]  G. Lip,et al.  Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. , 1995, British heart journal.

[16]  B. Chong,et al.  Plasma P-selectin is increased in thrombotic consumptive platelet disorders , 1994 .

[17]  S. Willich,et al.  Circadian Variation of Sudden Cardiac Death Reflects Age‐Related Variability in Ventricular Fibrillation , 1993, Circulation.

[18]  J. Amiral,et al.  Levels of plasma thrombomodulin are increased in atheromatous arterial disease. , 1993, Thrombosis research.

[19]  S. Hifumi,et al.  Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[20]  S. Willich,et al.  Increased onset of sudden cardiac death in the first three hours after awakening. , 1992, The American journal of cardiology.

[21]  P. Pepe,et al.  Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests. , 1992, JAMA.

[22]  E. Mammen,et al.  Circadian variation in platelet function in healthy volunteers. , 1992, The American journal of cardiology.

[23]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[24]  M. Mclaren,et al.  Circadian variation of endothelial cell function, red blood cell deformability and dehydro‐thromboxane B2 in healthy volunteers , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  H. Ishii,et al.  Soluble Thrombomodulin Antigen in Conditioned Medium Is Increased by Damage of Endothelial Cells , 1991, Thrombosis and Haemostasis.

[26]  K. Hirokawa,et al.  Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. , 1990, Journal of biochemistry.

[27]  T. Kamada,et al.  Increased intracardiovascular clotting in patients with chronic atrial fibrillation. , 1990, Journal of the American College of Cardiology.

[28]  A. Quyyumi,et al.  CIRCADIAN VARIATION OF TOTAL ISCHAEMIC BURDEN AND ITS ALTERATION WITH ANTI-ANGINAL AGENTS , 1988, The Lancet.

[29]  E F Cook,et al.  Circadian variation of transient myocardial ischemia in patients with coronary artery disease. , 1987, Circulation.

[30]  D. Beevers,et al.  Diurnal variation of and activity during the onset of stroke. , 1985, Neurosurgery.

[31]  E. Braunwald,et al.  Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.

[32]  J. Gris,et al.  Circadian changes in anticoagulant effect of heparin infused at a constant rate. , 1985, British medical journal.

[33]  G. Wenham,et al.  Circadian changes in anticoagulant effect of heparin infused at a constant rate. , 1985, British medical journal.

[34]  J. Marshall.  Diurnal Variation in Occurrence of Strokes , 1977, Stroke.

[35]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[36]  A. Camm,et al.  Patients with non-valvular atrial fibrillation have evidence of thrombin generation but not endothelial activation , 1998 .

[37]  S. Amitani,et al.  Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[38]  M. Gadsden,et al.  Variation of Occurrence , 1989 .

[39]  S. Willich,et al.  Circadian variation in the frequency of sudden cardiac death. , 1987, Circulation.